Recognized medical experts across various specialties
Dr. Alessandro Rossi is a world-renowned cardiologist specializing in interventional procedures and heart failure management. With over 25 years of experience, he has performed more than 10,000 cardiac catheterizations and 5,000 angioplasties, establishing himself as a leader in minimally invasive cardiac treatments.
After completing his medical degree at the University of Milan, Dr. Rossi pursued advanced training at the Cleveland Clinic. He has published over 200 peer-reviewed articles and developed several innovative techniques for treating complex coronary artery disease. His research on drug-eluting stents has been widely recognized and implemented globally.
Currently serving as the Director of Cardiology at Milan's prestigious San Raffaele Hospital, Dr. Rossi leads a team that performs cutting-edge procedures including TAVR and MitraClip. He has received numerous awards including the European Society of Cardiology Gold Medal for his contributions to cardiovascular medicine.
Dr. Sofia Bianchi is a leading neurologist specializing in multiple sclerosis and neurodegenerative disorders. Her groundbreaking work in neuroimmunology has transformed treatment protocols for MS patients across Europe. With 18 years of clinical experience, she has treated over 3,000 patients with complex neurological conditions.
Educated at the University of Rome, Dr. Bianchi completed her fellowship at Johns Hopkins Hospital. She developed the "Bianchi Protocol" for early intervention in progressive MS, which has been adopted by 15 countries. Her research focuses on the gut-brain axis and its implications for autoimmune neurological diseases.
As head of the Neurology Department at Gemelli University Hospital, Dr. Bianchi oversees Italy's largest MS center. She has received the International MS Federation's Lifetime Achievement Award and serves on the editorial boards of three major neurology journals. Her patient-centered approach combines cutting-edge treatments with holistic care.
Dr. Marco Ferrari is Italy's foremost orthopedic surgeon specializing in complex joint replacements and sports medicine. With 22 years of surgical experience, he has performed over 8,000 joint replacement procedures with exceptional outcomes. His expertise in minimally invasive techniques has reduced recovery times by 40% compared to traditional methods.
After training at the Rizzoli Orthopedic Institute, Dr. Ferrari developed innovative approaches to robotic-assisted knee and hip replacements. He pioneered the "Ferrari Technique" for cartilage regeneration, which has helped elite athletes return to competition after severe joint injuries. His patients include Olympic medalists and professional football players.
Currently Director of Orthopedics at Humanitas Research Hospital, Dr. Ferrari leads Italy's largest joint replacement program. He has trained over 200 surgeons worldwide and holds patents for three orthopedic devices. His research on biomaterials for joint prostheses has been published in Nature Medicine and The Lancet.
Dr. Elena Romano is a distinguished pediatrician specializing in neonatal care and childhood autoimmune disorders. With two decades of experience, she has treated over 15,000 children and established Italy's first integrated pediatric autoimmune clinic. Her compassionate approach and diagnostic acumen have made her one of the most sought-after pediatric specialists.
After graduating summa cum laude from the University of Bologna, Dr. Romano completed her residency at Boston Children's Hospital. She developed groundbreaking protocols for managing juvenile diabetes that have reduced complications by 60%. Her work on early detection of pediatric rheumatic diseases has been adopted as standard practice across Europe.
As Chief of Pediatrics at Bambino Gesù Children's Hospital in Rome, Dr. Romano oversees the largest pediatric research center in Italy. She has received the European Pediatric Association's Excellence Award three times and serves as Italy's representative to the World Health Organization's child health initiatives. Her dedication to vulnerable populations includes establishing free clinics for refugee children.
Dr. Giovanni Conti is a pioneering oncologist specializing in precision medicine for solid tumors. With 28 years of experience, he has treated over 5,000 cancer patients and developed personalized treatment protocols that have improved survival rates for aggressive cancers. His work in molecular profiling has revolutionized oncology practice in Italy.
Educated at the University of Turin, Dr. Conti completed his fellowship at MD Anderson Cancer Center. He established Italy's first comprehensive molecular tumor board and developed the "Conti Index" for predicting immunotherapy response in lung cancer patients. His clinical trials on targeted therapies have led to three FDA-approved treatments.
As Scientific Director of the National Cancer Institute in Milan, Dr. Conti oversees Italy's largest cancer research program. He has received the ESMO Lifetime Achievement Award and serves on the Nobel Prize nominating committee for Medicine. His patient advocacy work includes founding Italy's first nationwide genetic counseling network for hereditary cancers.
Dr. Luca Marchetti is a world-class neurosurgeon specializing in complex brain tumor resections and minimally invasive spine surgery. With 19 years of experience, he has performed over 3,500 neurosurgical procedures with exceptional outcomes. His expertise in awake craniotomies for eloquent area tumors has preserved neurological function in countless patients.
After training at the University of Padua, Dr. Marchetti completed advanced fellowships at the Barrow Neurological Institute. He developed the "Marchetti Approach" for skull base tumors, reducing surgical morbidity by 45%. His work on intraoperative MRI guidance has set new standards for precision in neurosurgery.
Currently serving as Chairman of Neurosurgery at Niguarda Hospital in Milan, Dr. Marchetti leads Italy's most advanced neuro-oncology program. He has trained neurosurgeons from 12 countries and holds patents for three neurosurgical devices. His research on liquid biopsy for brain tumors has been published in top-tier journals including Nature Neuroscience.
Dr. Francesca Esposito is Italy's leading expert in cardiac electrophysiology and complex arrhythmia management. With 16 years of experience, she has performed over 4,000 ablation procedures with a 98% success rate. Her innovative approaches to treating atrial fibrillation have made her a sought-after specialist throughout Europe.
Educated at the University of Naples, Dr. Esposito completed her fellowship at the Texas Heart Institute. She developed the "Esposito Protocol" for persistent AF ablation, which has become the gold standard in many centers. Her work on substrate mapping has significantly improved outcomes for ventricular tachycardia patients.
As Director of the Arrhythmia Center at Monzino Cardiology Center in Milan, Dr. Esposito oversees Italy's most advanced EP program. She has received the European Heart Rhythm Association's Young Investigator Award and serves on the writing committee for international AF guidelines. Her research on pulsed field ablation is shaping the future of cardiac rhythm management.
Dr. Matteo De Luca is a renowned plastic surgeon specializing in microsurgical reconstruction and aesthetic surgery. With 21 years of experience, he has performed over 5,000 complex reconstructive procedures and 3,000 aesthetic surgeries. His expertise in DIEP flap breast reconstruction has helped countless cancer survivors regain confidence and quality of life.
After training at the University of Florence, Dr. De Luca completed fellowships at NYU Langone and the Buncke Clinic in San Francisco. He pioneered the "De Luca Technique" for facial reanimation in paralysis patients, combining nerve transfers with microsurgical precision. His work on scarless breast reconstruction has been featured in international medical journals.
Currently heading the Plastic Surgery Department at San Donato Hospital, Dr. De Luca leads Italy's premier reconstructive microsurgery program. He has received the European Association of Plastic Surgeons' Innovation Award three times and serves as visiting professor at five international universities. His humanitarian work includes leading surgical missions for congenital deformity correction in developing countries.
Dr. Chiara Rinaldi is a leading gastroenterologist specializing in inflammatory bowel disease and advanced endoscopic procedures. With 17 years of experience, she has performed over 8,000 complex endoscopic interventions and established Italy's first dedicated IBD center. Her work on personalized treatment algorithms for Crohn's disease has influenced European guidelines.
After completing her medical degree at the University of Bologna, Dr. Rinaldi trained at the Mayo Clinic. She developed the "Rinaldi Score" for predicting treatment response in ulcerative colitis, which is now used worldwide. Her research on the gut microbiome's role in IBD has opened new therapeutic avenues.
As Chief of Gastroenterology at Sant'Orsola Hospital, Dr. Rinaldi oversees Italy's largest IBD referral center. She has received the United European Gastroenterology Federation's Rising Star Award and serves on the editorial board of Gastroenterology. Her patient-centered approach combines cutting-edge therapies with nutritional and psychological support.
Dr. Antonio Greco is Italy's foremost endocrinologist specializing in pituitary disorders and neuroendocrine tumors. With 23 years of experience, he has treated over 2,000 patients with complex endocrine conditions. His expertise in acromegaly and Cushing's disease management has made him a global authority in neuroendocrinology.
Educated at the University of Pisa, Dr. Greco completed his fellowship at the National Institutes of Health. He developed the "Greco Classification" for pituitary adenomas, which guides treatment decisions worldwide. His research on somatostatin receptor imaging has revolutionized the diagnosis of neuroendocrine tumors.
Currently serving as Director of Endocrinology at Careggi University Hospital in Florence, Dr. Greco leads Italy's largest pituitary tumor program. He has received the European Society of Endocrinology's Outstanding Clinician Award and serves as president-elect of the International Society of Endocrinology. His translational research bridges cutting-edge science with clinical practice.
Dr. Roberto Lombardi is a pioneering urologist specializing in robotic prostatectomy and kidney preservation surgery. With 20 years of experience, he has performed over 3,000 robotic procedures with exceptional oncological and functional outcomes. His nerve-sparing techniques have preserved urinary and sexual function in 90% of prostate cancer patients.
After training at the University of Turin, Dr. Lombardi completed a fellowship at the Vattikuti Urology Institute in Detroit. He developed the "Lombardi Technique" for partial nephrectomy, which maximizes kidney function preservation while ensuring complete tumor removal. His work on intraoperative fluorescence imaging has reduced positive surgical margins by 60%.
Currently heading the Robotic Surgery Program at San Luigi Gonzaga Hospital, Dr. Lombardi trains surgeons from across Europe. He has received the European Association of Urology's Innovation Award and serves on the guidelines panel for prostate cancer management. His research focuses on AI-assisted surgical decision-making in urologic oncology.
Dr. Giulia Santoro is a leading dermatologist specializing in melanoma and cosmetic dermatology. With 15 years of experience, she has treated over 1,000 melanoma patients and performed 5,000 aesthetic procedures. Her expertise in early melanoma detection using advanced dermoscopy has saved countless lives through timely intervention.
Educated at the University of Rome, Dr. Santoro completed her fellowship at Memorial Sloan Kettering Cancer Center. She developed the "Santoro Algorithm" for melanoma risk stratification, which is used in dermatology practices worldwide. Her research on non-invasive skin imaging techniques has revolutionized early cancer detection.
As Director of the Dermatology Institute in Milan, Dr. Santoro leads Italy's most advanced pigmented lesion clinic. She has received the European Academy of Dermatology's Gold Medal and serves on the World Health Organization's skin cancer prevention task force. Her holistic approach combines cutting-edge treatments with preventive strategies and patient education.
Dr. Paolo Moretti is Italy's foremost ophthalmologist specializing in retinal diseases and complex cataract surgery. With 24 years of experience, he has performed over 15,000 retinal procedures and 20,000 cataract surgeries. His expertise in macular hole repair and retinal detachment surgery has restored vision to thousands of patients.
After training at the University of Padua, Dr. Moretti completed fellowships at Moorfields Eye Hospital and Bascom Palmer Eye Institute. He pioneered the "Moretti Technique" for complex cataract extraction in eyes with compromised zonules, which has become standard practice. His work on gene therapy for inherited retinal diseases has been groundbreaking.
Currently serving as Director of the Eye Institute in Verona, Dr. Moretti leads Italy's largest retina service. He has received the European Society of Retina Specialists' Lifetime Achievement Award and holds patents for three ophthalmic devices. His research on sustained-release drug delivery for macular degeneration is transforming treatment paradigms.
Dr. Elena Fiore is a distinguished pulmonologist specializing in interstitial lung diseases and advanced bronchoscopy. With 19 years of experience, she has diagnosed and treated over 3,000 patients with rare lung conditions. Her expertise in idiopathic pulmonary fibrosis has made her a leading authority in this challenging field.
After completing her medical degree at the University of Naples, Dr. Fiore trained at National Jewish Health in Denver. She developed the "Fiore Criteria" for predicting disease progression in fibrotic lung disorders, which guides treatment decisions worldwide. Her research on biomarkers for early detection of lung fibrosis has been published in top respiratory journals.
As Head of the ILD Center at Monaldi Hospital in Naples, Dr. Fiore oversees Italy's largest interstitial lung disease program. She has received the European Respiratory Society's Gold Medal and serves on the steering committee for international IPF guidelines. Her multidisciplinary approach combines cutting-edge diagnostics with comprehensive patient support services.
Dr. Marco Barbieri is Italy's leading rheumatologist specializing in systemic sclerosis and connective tissue diseases. With 22 years of experience, he has treated over 2,500 patients with complex autoimmune conditions. His expertise in early diagnosis and aggressive treatment of scleroderma has significantly improved outcomes for this challenging disease.
Educated at the University of Florence, Dr. Barbieri completed his fellowship at the University of California, Los Angeles. He developed the "Barbieri Protocol" for managing scleroderma renal crisis, reducing mortality by 70%. His research on endothelial dysfunction in rheumatic diseases has opened new therapeutic avenues.
Currently serving as Director of Rheumatology at Santa Maria Nuova Hospital, Dr. Barbieri leads Italy's largest scleroderma center. He has received the European League Against Rheumatism's Distinguished Investigator Award and serves on the editorial board of Arthritis & Rheumatology. His translational research bridges basic science with clinical applications to improve patient care.
Dr. Laura Gentile is a renowned hematologist specializing in leukemia and stem cell transplantation. With 21 years of experience, she has performed over 1,000 bone marrow transplants with exceptional outcomes. Her expertise in haploidentical transplantation has made curative treatment accessible to patients without matched donors.
After training at the University of Bologna, Dr. Gentile completed her fellowship at Fred Hutchinson Cancer Research Center. She developed the "Gentile Protocol" for reduced-intensity conditioning, enabling transplantation in elderly and frail patients. Her research on graft-versus-host disease prevention has significantly improved transplant safety.
Currently serving as Director of Hematology at Sant'Orsola Hospital, Dr. Gentile leads Italy's largest transplant program. She has received the European Hematology Association's Clinical Research Award and serves on the board of the Worldwide Network for Blood and Marrow Transplantation. Her work has expanded access to curative therapies for blood cancers.
Dr. Stefano Rizzo is Italy's foremost nephrologist specializing in glomerular diseases and kidney transplantation. With 25 years of experience, he has treated over 3,000 patients with complex kidney disorders and supervised 1,500 transplants. His expertise in antibody-mediated rejection has improved graft survival rates nationwide.
Educated at the University of Milan, Dr. Rizzo completed advanced training at Brigham and Women's Hospital. He developed the "Rizzo Classification" for lupus nephritis, which guides treatment decisions globally. His research on complement inhibition in kidney disease has led to two FDA-approved therapies.
As Chief of Nephrology at Policlinico di Milano, Dr. Rizzo oversees Italy's largest glomerular disease center. He has received the International Society of Nephrology's Presidential Award and serves on the editorial board of Kidney International. His translational research bridges molecular biology with clinical nephrology to develop targeted therapies.
Dr. Anna Lombardo is a leading psychiatrist specializing in treatment-resistant depression and neuromodulation therapies. With 18 years of experience, she has treated over 2,000 patients with severe mood disorders. Her expertise in transcranial magnetic stimulation (TMS) has brought relief to countless patients unresponsive to medications.
After completing her medical degree at the University of Rome, Dr. Lombardo trained at Columbia University. She developed the "Lombardo Protocol" for accelerated TMS, reducing treatment duration by 50% while maintaining efficacy. Her research on biomarkers for depression treatment response has been published in leading psychiatric journals.
Currently serving as Director of the Mood Disorders Center at Gemelli Hospital, Dr. Lombardo leads Italy's most advanced neuromodulation program. She has received the European Psychiatric Association's Young Investigator Award and serves on the board of the International Society for Affective Disorders. Her integrative approach combines biological therapies with psychotherapy.
Dr. Carlo Romano is Italy's foremost infectious disease specialist, renowned for his work on antimicrobial resistance and tropical medicine. With 27 years of experience, he has treated over 5,000 patients with complex infections and established national protocols for antibiotic stewardship. His expertise in multidrug-resistant organisms has shaped Italy's approach to infection control.
Educated at the University of Naples, Dr. Romano completed his fellowship at the London School of Hygiene & Tropical Medicine. He developed the "Romano Score" for predicting outcomes in sepsis, which is used in ICUs worldwide. His research on rapid diagnostics for bloodstream infections has reduced mortality by 30% in participating hospitals.
As Director of Infectious Diseases at Cotugno Hospital, Dr. Romano leads Italy's reference center for tropical diseases and antimicrobial resistance. He has received the European Society of Clinical Microbiology's Gold Medal and serves as Italy's delegate to the WHO's AMR committee. His global health work includes establishing diagnostic labs in developing countries.
Dr. Silvia Martini is a distinguished allergist specializing in severe food allergies and immune deficiencies. With 16 years of experience, she has treated over 3,000 patients with complex allergic conditions. Her expertise in oral immunotherapy for food allergies has enabled hundreds of patients to safely consume previously allergenic foods.
After training at the University of Genoa, Dr. Martini completed her fellowship at National Jewish Health. She developed the "Martini Protocol" for rapid desensitization to multiple food allergens, achieving 85% success rates. Her research on biomarkers predicting anaphylaxis risk has been published in top allergy journals.
Currently heading the Allergy Center at Gaslini Children's Hospital, Dr. Martini leads Italy's largest pediatric allergy program. She has received the European Academy of Allergy's Young Investigator Award and serves on the guidelines committee for food allergy management. Her patient-centered approach combines cutting-edge treatments with comprehensive education.
Dr. Enrico Ferrara is Italy's most respected geriatrician, specializing in comprehensive care for the elderly and dementia management. With 30 years of experience, he has treated over 10,000 older adults with complex medical conditions. His expertise in polypharmacy reduction has significantly improved quality of life for countless seniors.
After completing his medical degree at the University of Padua, Dr. Ferrara trained at Johns Hopkins University. He developed the "Ferrara Index" for predicting functional decline in hospitalized elders, which is used in geriatric units worldwide. His research on non-pharmacological dementia interventions has influenced European guidelines.
As Director of Geriatrics at INRCA Hospital, Dr. Ferrara leads Italy's premier aging research center. He has received the European Union Geriatric Medicine Society's Lifetime Achievement Award and serves on the WHO's expert panel on aging. His patient-centered model integrates medical care with social support and rehabilitation.
Dr. Maria Gallo is a renowned obstetrician-gynecologist specializing in high-risk pregnancies and minimally invasive gynecologic surgery. With 22 years of experience, she has delivered over 5,000 babies and performed 3,000 complex gynecologic procedures. Her expertise in managing placenta accreta has made her Italy's go-to specialist for this life-threatening condition.
Educated at the University of Bologna, Dr. Gallo completed her fellowship at Baylor College of Medicine. She developed the "Gallo Technique" for uterine preservation in abnormal placentation, reducing hysterectomy rates by 70%. Her research on preterm birth prediction has been implemented in prenatal clinics nationwide.
Currently serving as Director of Maternal-Fetal Medicine at Sant'Anna Hospital, Dr. Gallo leads Italy's largest high-risk pregnancy program. She has received the International Federation of Gynecology and Obstetrics' Distinguished Service Award and serves on Italy's maternal mortality review board. Her commitment to safe motherhood extends to training programs in developing countries.
Dr. Luca Marino is Italy's leading pediatric surgeon specializing in minimally invasive techniques and neonatal surgery. With 19 years of experience, he has performed over 4,000 complex procedures on children, including 1,000 neonatal operations. His expertise in thoracoscopic repair of congenital diaphragmatic hernia has reduced mortality by 50% in his center.
After training at the University of Padua, Dr. Marino completed fellowships at Boston Children's Hospital and Great Ormond Street Hospital. He pioneered the "Marino Approach" for single-incision pediatric surgery, minimizing scarring and recovery time. His work on fetal surgery for spina bifida has been groundbreaking.
Currently heading Pediatric Surgery at Bambino Gesù Hospital, Dr. Marino leads Italy's most advanced pediatric surgical center. He has received the European Pediatric Surgeons' Association's Innovation Award and serves on the board of the World Federation of Pediatric Surgeons. His humanitarian work includes surgical missions for congenital anomalies.
Dr. Giovanni Costa is Italy's foremost anesthesiologist specializing in complex cardiac and transplant anesthesia. With 24 years of experience, he has provided anesthesia for over 15,000 high-risk procedures. His expertise in hemodynamic management during liver transplantation has contributed to his center's world-class outcomes.
Educated at the University of Milan, Dr. Costa trained at the Mayo Clinic and Massachusetts General Hospital. He developed the "Costa Algorithm" for fluid management in major surgery, reducing complications by 40%. His research on cerebral oximetry monitoring has improved neurological outcomes after cardiac surgery.
Currently serving as Chief of Anesthesiology at Niguarda Hospital, Dr. Costa leads Italy's largest transplant anesthesia team. He has received the European Society of Anesthesiology's Gold Medal and serves on the board of the International Anesthesia Research Society. His work has set new standards for patient safety in complex surgeries.
Dr. Francesca De Angelis is a leading radiation oncologist specializing in proton therapy and pediatric radiation oncology. With 17 years of experience, she has treated over 2,000 cancer patients with precision radiotherapy. Her expertise in proton therapy for childhood cancers has minimized long-term side effects while maintaining excellent cure rates.
After completing her medical degree at the University of Rome, Dr. De Angelis trained at MD Anderson Cancer Center and Massachusetts General Hospital. She developed the "De Angelis Protocol" for craniospinal irradiation in pediatric patients, reducing neurocognitive decline by 60%. Her research on FLASH radiotherapy has been groundbreaking.
Currently serving as Director of the Proton Therapy Center at CNAO in Pavia, Dr. De Angelis leads Italy's most advanced radiation oncology program. She has received the European Society for Radiotherapy and Oncology's Young Investigator Award and serves on the board of the Particle Therapy Co-Operative Group. Her work is shaping the future of cancer treatment.
Dr. Andrea Romano is Italy's foremost emergency medicine specialist, renowned for his work in disaster medicine and mass casualty management. With 20 years of experience, he has treated over 50,000 emergency cases and led responses to major disasters. His expertise in field triage and emergency systems has saved countless lives during crises.
Educated at the University of Naples, Dr. Romano trained at Bellevue Hospital in New York and completed military medical training. He developed the "Romano Protocol" for mass casualty triage, which has been adopted by NATO and the United Nations. His research on hemorrhage control in prehospital settings has reduced preventable trauma deaths by 35%.
Currently serving as Director of Emergency Medicine at Policlinico Umberto I, Dr. Romano leads Italy's busiest trauma center. He has received the World Association for Disaster and Emergency Medicine's Gold Medal and serves as Italy's representative to the European Emergency Number Association. His training programs have improved emergency response nationwide.
Dr. Silvia Conti is a distinguished pathologist specializing in molecular diagnostics and digital pathology. With 23 years of experience, she has reviewed over 100,000 pathology cases and established Italy's first fully digital pathology department. Her expertise in rare tumor classification has made her a sought-after consultant worldwide.
After training at the University of Bologna, Dr. Conti completed fellowships at Johns Hopkins and Memorial Sloan Kettering. She developed the "Conti Panel" for molecular classification of sarcomas, which guides treatment decisions globally. Her research on AI-assisted pathology has been published in Nature Medicine and The Lancet Oncology.
Currently serving as Chief of Pathology at Rizzoli Orthopedic Institute, Dr. Conti leads Italy's reference center for bone and soft tissue tumors. She has received the United States and Canadian Academy of Pathology's Distinguished Pathologist Award and serves on the editorial board of Modern Pathology. Her work is transforming cancer diagnosis through technology.
Dr. Marco De Santis is Italy's leading specialist in physical medicine and rehabilitation, focusing on spinal cord injury and neurorehabilitation. With 21 years of experience, he has treated over 2,000 patients with severe neurological impairments. His expertise in functional electrical stimulation has enabled paralyzed patients to regain meaningful movement.
Educated at the University of Rome, Dr. De Santis trained at the Rehabilitation Institute of Chicago and the Swiss Paraplegic Centre. He developed the "De Santis Protocol" for intensive locomotor training after spinal cord injury, improving walking recovery by 300% compared to conventional therapy. His research on brain-computer interfaces has been groundbreaking.
Currently serving as Director of the Spinal Cord Injury Center at Santa Lucia Hospital, Dr. De Santis leads Italy's most advanced neurorehabilitation program. He has received the International Spinal Cord Society's Lifetime Achievement Award and serves on the board of the European Society of Physical and Rehabilitation Medicine. His work has redefined recovery expectations for neurological patients.
Dr. Elena Marini is Italy's most respected family physician, renowned for her comprehensive approach to primary care and preventive medicine. With 28 years of experience, she has cared for over 5,000 patients across generations. Her expertise in managing complex multimorbidity has made her a model for holistic primary care.
After completing her medical degree at the University of Florence, Dr. Marini trained at the University of Toronto's Department of Family Medicine. She developed the "Marini Model" for integrated primary care, reducing hospital admissions by 25% in her practice. Her research on social determinants of health has influenced national primary care policies.
Currently serving as President of the Italian College of General Practitioners, Dr. Marini leads initiatives to strengthen primary care nationwide. She has received the World Organization of Family Doctors' Five-Star Doctor Award and serves on the WHO's expert panel on primary health care. Her patient-centered practice combines clinical excellence with community engagement.
Dr. Paolo Gentili is Italy's foremost palliative care specialist, dedicated to improving quality of life for patients with serious illnesses. With 19 years of experience, he has cared for over 3,000 patients and their families during challenging health journeys. His expertise in complex symptom management has brought comfort to countless individuals.
Educated at the University of Milan, Dr. Gentili completed fellowships at St. Christopher's Hospice in London and Memorial Sloan Kettering. He developed the "Gentili Approach" to integrated palliative care, ensuring seamless transitions between curative and comfort-focused treatments. His research on early palliative intervention has shown significant survival benefits.
Currently serving as Director of Palliative Care at San Carlo Borromeo Hospital, Dr. Gentili leads Italy's largest palliative care network. He has received the European Association for Palliative Care's Humanitarian Award and serves on Italy's national committee for end-of-life care guidelines. His compassionate leadership has transformed perceptions of palliative medicine nationwide.